back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-18 12:34 Tx date 2026-06-18 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,400
-600 vol $14.00 each |
177,009 | |
| Older filings | ||||||
| Filed 2026-06-11 16:52 Tx date 2026-06-11 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,230
-300 vol $14.10 each |
177,609 | |
| Filed 2026-06-11 14:22 Tx date 2026-06-11 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,200
-300 vol $14.00 each |
177,909 | |
| Filed 2026-06-11 14:20 Tx date 2026-06-10 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,200
-300 vol $14.00 each |
178,209 | |
| Filed 2026-06-11 14:20 Tx date 2026-06-10 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,170
-300 vol $13.90 each |
178,509 | |
| Filed 2026-05-31 17:33 Tx date 2026-05-29 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,810
-200 vol $14.05 each |
178,809 | |
| Filed 2026-05-28 19:25 Tx date 2026-05-28 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,405
-100 vol $14.05 each |
179,009 | |
| Filed 2026-05-26 17:26 Tx date 2026-05-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,230
-300 vol $14.10 each |
179,109 | |
| Filed 2026-05-26 17:25 Tx date 2026-05-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,200
-300 vol $14.00 each |
179,409 | |
| Filed 2026-05-26 17:24 Tx date 2026-05-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,155
-300 vol $13.85 each |
179,709 | |
| Filed 2026-05-26 17:22 Tx date 2026-05-25 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,125
-300 vol $13.75 each |
180,009 | |
| Filed 2026-04-01 14:57 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,699
+742 vol $14.42 each |
180,309 | |
| Filed 2026-04-01 14:51 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-1,484 vol |
2,116 | |
| Filed 2026-03-31 12:45 Tx date 2026-03-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,470
-100 vol $14.70 each |
179,567 | |
| Filed 2026-03-27 13:35 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+3,600 vol |
3,600 | |
| Filed 2026-03-27 13:32 Tx date 2002-06-25 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-27 13:06 Tx date 2026-03-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,470
-100 vol $14.70 each |
179,767 | |
| Filed 2026-03-27 13:05 Tx date 2026-03-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,475
-100 vol $14.75 each |
179,667 | |
| Filed 2026-03-27 13:03 Tx date 2026-03-26 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,470
+100 vol $14.70 each |
||
| Filed 2026-03-17 07:59 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,422
+291 vol $11.76 each |
179,867 | |